Pharma-Bio Serv, Inc. (PBSV)
Stock Price:
$1.05 USD
0.04 (3.96%)
Updated Aug 13, 2020 4:00 PM EDT - End of day
Key Info
| Market Cap |
24.15M |
| Revenue (ttm) |
20.05M |
| Net Income (ttm) |
2.12M |
| Shares Out |
23.00M |
| EPS (ttm) |
0.09 |
| PE Ratio |
11.67 |
| Forward PE |
n/a |
| Dividend |
$0.07 |
| Dividend Yield |
6.67% |
Stock Quote
| Trading Day |
Aug 13, 2020 |
| Last Price |
$1.05 |
| Previous Close |
$1.01 |
| Change ($) |
0.04 |
| Change (%) |
3.96% |
| Day's Open |
1.05 |
| Day's Range |
1.05 - 1.05 |
| Day's Volume |
1,219 |
| 52-Week Range |
0.60 - 1.09 |
More Stats
| Market Cap |
24.15M |
| Enterprise Value |
11.43M |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
23.00M |
| Float |
11.47M |
| EPS (basic) |
0.092 |
| EPS (diluted) |
0.09 |
| FCF / Share |
-0.06 |
| Dividend |
$0.07 |
| Dividend Yield |
6.67% |
| Earnings Yield |
8.57% |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
n/a |
| Short Ratio |
n/a |
| Short % of Float |
n/a |
| Beta |
0.33 |
| PE Ratio |
11.67 |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
1.20 |
| PB Ratio |
1.11 |
| Revenue |
20.05M |
| Operating Income |
2.04M |
| Net Income |
2.12M |
| Free Cash Flow |
-1.25M |
| Net Cash |
12.72M |
| Net Cash / Share |
0.55 |
| Gross Margin |
30.80% |
| Operating Margin |
10.20% |
| Profit Margin |
10.60% |
| FCF Margin |
-6.25% |
| ROA |
4.71% |
| ROE |
9.84% |
| ROIC |
n/a |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Low
2.25
Current: $1.05
High
2.25
Target: 2.25
*Average 12-month price target from 1 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|
| Revenue | 19.51 | 17.80 | 13.30 | 19.54 | 23.38 | 27.56 | 33.06 | 29.23 | 19.93 | 11.35 |
| Revenue Growth | 9.61% | 33.84% | -31.94% | -16.46% | -15.13% | -16.66% | 13.12% | 46.63% | 75.68% | - |
| Gross Profit | 6.18 | 5.69 | 3.84 | 5.78 | 7.48 | 8.97 | 11.83 | 9.87 | 6.86 | 3.39 |
| Operating Income | 1.70 | 1.09 | -0.82 | -0.09 | 1.78 | 2.86 | 6.07 | 5.73 | 3.45 | 0.61 |
| Net Income | 2.09 | 1.28 | -1.41 | -0.26 | 1.62 | 2.41 | 4.91 | 4.69 | 3.16 | 0.37 |
| Shares Outstanding | 23.05 | 23.08 | 23.10 | 23.02 | 23.07 | 22.98 | 22.20 | 20.76 | 20.75 | 20.75 |
| Earnings Per Share | 0.09 | 0.06 | -0.06 | -0.01 | 0.07 | 0.10 | 0.21 | 0.20 | 0.14 | 0.02 |
| EPS Growth | 63.64% | - | - | - | -32.35% | -50.72% | 1.47% | 45.71% | 723.53% | - |
| Operating Cash Flow | -2.21 | 4.45 | -1.71 | 0.71 | 0.37 | 3.33 | 5.63 | 2.46 | 2.14 | 0.47 |
| Capital Expenditures | 0.04 | -0.12 | -0.01 | -1.78 | -0.34 | -0.17 | -0.21 | -0.17 | -0.12 | -0.05 |
| Free Cash Flow | -2.17 | 4.33 | -1.72 | -1.07 | 0.03 | 3.16 | 5.42 | 2.29 | 2.02 | 0.42 |
| Cash & Equivalents | 15.49 | 16.07 | 11.62 | 13.79 | 14.93 | 15.16 | 12.12 | 6.63 | 4.41 | 2.41 |
| Total Debt | 0.08 | 0.06 | 0.07 | 0.05 | 0.07 | 0.10 | 0.08 | 0.12 | 0.12 | 0.07 |
| Net Cash / Debt | 15.41 | 16.01 | 11.54 | 13.74 | 14.85 | 15.06 | 12.03 | 6.51 | 4.29 | 2.34 |
| Assets | 26.63 | 25.38 | 22.35 | 24.00 | 24.14 | 23.21 | 21.28 | 15.74 | 10.85 | 6.56 |
| Liabilities | 6.03 | 5.11 | 1.60 | 2.19 | 2.18 | 2.70 | 3.23 | 2.86 | 2.62 | 1.49 |
| Book Value | 20.61 | 20.26 | 20.75 | 21.81 | 21.96 | 20.51 | 18.05 | 12.88 | 8.24 | 5.07 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Pharma-Bio Serv, Inc. |
| Country |
Puerto Rico |
| Employees |
185 |
| CEO |
Victor Sanchez |
Stock Information
| Ticker Symbol |
PBSV |
| Stock Exchange |
US OTC |
| Sector |
Healthcare |
| Industry |
Health Information Services |
| Unique Identifier |
OTCMKTS: PBSV |
Description
Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm the United States, Europe, and Brazil markets. It provides compliance consulting services to the pharmaceutical, chemical, biotechnology, medical device, cosmetic, food industries, and allied products in Puerto Rico, the United States, Europe, and Brazil. The company's technical consulting services comprise regulatory compliance, validation, technology transfer, engineering, project management, and process support. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico.